Opportunity ID: 157093

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAS-12-122
Funding Opportunity Title: Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 21, 2012
Last Updated Date: Jul 18, 2013
Original Closing Date for Applications: Dec 04, 2014
Current Closing Date for Applications: Jul 18, 2013
Archive Date: Aug 18, 2013
Estimated Total Program Funding:
Award Ceiling: $2,000,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Native American tribal governments (Federally recognized)
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Private institutions of higher education
Special district governments
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in theNIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: NIDA grant-funded research programs aiming to develop medications for the treatment of Substance Use Disorders (SUDs) are often hindered by a lack of both human and financial resources. Drug development is a long process that requires teams of people with a wide range of individual skill sets. Consequently, individual grantees with the skills to get through the preclinical stages of drug development often fail to transition their project through the clinic and into the market place. Grantees frequently lack both real world experience of the drug development process and the financial resources to advance a medication to the market place in the necessary timeframe. The purpose of this Funding Opportunity Announcement (FOA) is to help support these efforts to meet these objectives by leveraging the strengths of two or more organizations toward a common goal of medications development.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAS-12-122.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Modified Archive Date based on new Expiration Date, per NOT-DA-13-042. Jul 18, 2013
Jul 18, 2013

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAS-12-122
Funding Opportunity Title: Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 21, 2012
Last Updated Date: Jul 18, 2013
Original Closing Date for Applications: Dec 04, 2014
Current Closing Date for Applications: Jul 18, 2013
Archive Date: Aug 18, 2013
Estimated Total Program Funding:
Award Ceiling: $2,000,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Native American tribal governments (Federally recognized)
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Private institutions of higher education
Special district governments
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in theNIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: NIDA grant-funded research programs aiming to develop medications for the treatment of Substance Use Disorders (SUDs) are often hindered by a lack of both human and financial resources. Drug development is a long process that requires teams of people with a wide range of individual skill sets. Consequently, individual grantees with the skills to get through the preclinical stages of drug development often fail to transition their project through the clinic and into the market place. Grantees frequently lack both real world experience of the drug development process and the financial resources to advance a medication to the market place in the necessary timeframe. The purpose of this Funding Opportunity Announcement (FOA) is to help support these efforts to meet these objectives by leveraging the strengths of two or more organizations toward a common goal of medications development.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAS-12-122.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAS-12-122
Funding Opportunity Title: Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 18, 2013
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Dec 04, 2014
Archive Date: Jan 04, 2015
Estimated Total Program Funding:
Award Ceiling: $2,000,000
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
State governments
Public and State controlled institutions of higher education
Small businesses
Independent school districts
Special district governments
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in theNIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: NIDA grant-funded research programs aiming to develop medications for the treatment of Substance Use Disorders (SUDs) are often hindered by a lack of both human and financial resources. Drug development is a long process that requires teams of people with a wide range of individual skill sets. Consequently, individual grantees with the skills to get through the preclinical stages of drug development often fail to transition their project through the clinic and into the market place. Grantees frequently lack both real world experience of the drug development process and the financial resources to advance a medication to the market place in the necessary timeframe. The purpose of this Funding Opportunity Announcement (FOA) is to help support these efforts to meet these objectives by leveraging the strengths of two or more organizations toward a common goal of medications development.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAS-12-122.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.279 ADOBE-FORMS-B2 ADOBE-FORMS-B2 PKG00109350 Jul 07, 2012 Jul 19, 2013 View

Package 1

Mandatory forms

157093 RR_SF424_1_2-1.2.pdf

157093 PerformanceSite_1_4-1.4.pdf

157093 RR_OtherProjectInfo_1_3-1.3.pdf

157093 RR_KeyPersonExpanded_1_2-1.2.pdf

157093 PHS398_CoverPageSupplement_1_4-1.4.pdf

157093 PHS398_ResearchPlan_1_3-1.3.pdf

157093 PHS398_Checklist_1_3-1.3.pdf

Optional forms

157093 RR_SubawardBudget30-1.2.pdf

157093 PHS398_ModularBudget_1_2-1.2.pdf

157093 RR_Budget-1.1.pdf

157093 PHS_CoverLetter_1_2-1.2.pdf

2025-07-14T05:29:38-05:00

Share This Post, Choose Your Platform!

About the Author: